title: In reference to what is the optimal perioperative management of antiplatelet therapy?
authors.affiliation: Department of Surgery, Division of Otolaryngology - Head and Neck Surgery, University of Alabama, Birmingham, Birmingham, Alabama, U.S.A.
authors.forename: Erin
authors.initials: E
authors.lastname: Partington
authors.affiliation: Department of Surgery, Division of Otolaryngology - Head and Neck Surgery, University of Alabama, Birmingham, Birmingham, Alabama, U.S.A.
authors.forename: Bradford A
authors.initials: BA
authors.lastname: Woodworth
authors.affiliation: Department of Neurosurgery, University of Alabama, Birmingham, Birmingham, Alabama, U.S.A.
authors.forename: Mark R
authors.initials: MR
authors.lastname: Harrigan
mesh_terms: D006801:Humans; D019990:Perioperative Care; D010975:Platelet Aggregation Inhibitors; D013988:Ticlopidine
chemical_list: D010975:Platelet Aggregation Inhibitors; D013988:Ticlopidine